| Amgen Inc., a biotechnology medicines company, engages in the discovery, development, manufacture, and marketing of human therapeutic products in the areas of supportive cancer care, inflammation, nephrology, and bone diseases primarily in the United States, Europe, and Canada. Its principal products include Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body fight infections; Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body's response to inflammatory diseases; Aranesp and EPOGEN erythropoiesis-stimulating agents that stimulate the production of red blood cells; and XGEVA/Prolia (denosumab) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides product candidates in mid- to late-stage development in various therapeutic areas comprising oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine, which includes neuroscience. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc; Takeda Pharmaceutical Company Limited; and UCB, as well as a strategic alliance with Astellas Pharma Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. |
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Amgen Ventures LLC | 10% Owner | Jun 05 | Buy | 15.00 | 16,666 | 249,990 | 334,126 | Jun 05 04:01 PM | | Dittrich Thomas J.W. | VP, Finance & CAO | May 22 | Option Exercise | 54.62 | 6,130 | 334,791 | 22,863 | May 24 05:18 PM | | Dittrich Thomas J.W. | VP, Finance & CAO | May 22 | Sale | 104.78 | 6,130 | 642,296 | 16,733 | May 24 05:18 PM | | Balachandran Madhavan | EVP, Operations | May 21 | Option Exercise | 50.44 | 6,000 | 302,640 | 46,956 | May 21 08:18 PM | | Balachandran Madhavan | EVP, Operations | May 21 | Sale | 103.28 | 6,000 | 619,681 | 34,851 | May 21 08:18 PM | | HENDERSON REBECCA M | Director | May 17 | Option Exercise | 55.76 | 7,000 | 390,310 | 13,898 | May 20 07:15 PM | | HENDERSON REBECCA M | Director | May 17 | Sale | 105.72 | 8,421 | 890,300 | 5,477 | May 20 07:15 PM | | Patton Cynthia M | SVP & CCO | May 16 | Option Exercise | 54.58 | 3,544 | 193,437 | 18,986 | May 17 05:42 PM | | Patton Cynthia M | SVP & CCO | May 16 | Sale | 105.01 | 3,544 | 372,148 | 15,442 | May 17 05:42 PM | | BIONDI FRANK | Director | May 14 | Option Exercise | 56.50 | 10,000 | 564,950 | 39,780 | May 16 05:38 PM | | PELHAM JUDITH C | Director | May 14 | Option Exercise | 55.47 | 25,000 | 1,386,650 | 48,149 | May 16 05:42 PM | | BIONDI FRANK | Director | May 14 | Sale | 108.43 | 10,000 | 1,084,318 | 29,780 | May 16 05:38 PM | | PELHAM JUDITH C | Director | May 14 | Sale | 108.25 | 25,000 | 2,706,165 | 23,149 | May 16 05:42 PM | | de Carbonnel Francois | Director | Apr 30 | Option Exercise | 54.74 | 10,000 | 547,400 | 21,930 | May 02 06:26 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 29 | Option Exercise | 50.44 | 10,000 | 504,400 | 64,643 | Apr 30 05:21 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 29 | Sale | 107.02 | 10,000 | 1,070,191 | 54,643 | Apr 30 05:21 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 26 | Option Exercise | 58.43 | 10,000 | 584,300 | 66,077 | Apr 30 05:21 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 26 | Sale | 107.99 | 10,000 | 1,079,872 | 56,077 | Apr 30 05:21 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 25 | Option Exercise | 54.69 | 8,662 | 473,725 | 65,973 | Apr 26 05:33 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 25 | Sale | 107.95 | 8,662 | 935,029 | 57,311 | Apr 26 05:33 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Apr 24 | Sale | 105.95 | 6,924 | 733,565 | 58,311 | Apr 26 05:33 PM | | de Carbonnel Francois | Director | Mar 13 | Option Exercise | 54.74 | 10,000 | 547,400 | 17,805 | Mar 14 06:18 PM | | BALTIMORE DAVID | Director | Feb 28 | Option Exercise | 74.89 | 5,000 | 374,450 | 35,526 | Mar 01 05:31 PM | | BALTIMORE DAVID | Director | Feb 28 | Sale | 92.94 | 886 | 82,345 | 30,526 | Mar 01 05:31 PM | | HERRINGER FRANK C | Director | Feb 26 | Option Exercise | 74.89 | 5,000 | 374,450 | 21,262 | Feb 26 06:20 PM | | PELHAM JUDITH C | Director | Feb 08 | Option Exercise | 62.55 | 5,000 | 312,750 | 26,304 | Feb 11 07:56 PM | | PELHAM JUDITH C | Director | Feb 08 | Sale | 86.94 | 5,000 | 434,715 | 21,304 | Feb 11 07:56 PM | | Bradway Robert A | President and CEO | Dec 20 | Option Exercise | 64.56 | 40,000 | 2,582,400 | 141,711 | Dec 20 06:34 PM | | BALTIMORE DAVID | Director | Dec 10 | Option Exercise | 50.78 | 16,000 | 812,480 | 46,526 | Dec 12 06:40 PM | | BALTIMORE DAVID | Director | Dec 10 | Sale | 89.00 | 6,800 | 605,220 | 30,526 | Dec 12 06:40 PM | | SCHAEFFER LEONARD D | Director | Dec 07 | Option Exercise | 51.71 | 15,000 | 775,600 | 31,329 | Dec 10 07:09 PM | | SCHAEFFER LEONARD D | Director | Dec 07 | Sale | 87.92 | 15,000 | 1,318,830 | 16,329 | Dec 10 07:09 PM | | BIONDI FRANK | Director | Nov 29 | Option Exercise | 74.89 | 5,000 | 374,450 | 32,833 | Nov 29 06:50 PM | | BIONDI FRANK | Director | Nov 29 | Sale | 88.10 | 5,000 | 440,512 | 27,833 | Nov 29 06:50 PM | | OMENN GILBERT S | Director | Nov 26 | Option Exercise | 57.68 | 26,000 | 1,499,680 | 202,783 | Nov 26 08:45 PM | | OMENN GILBERT S | Director | Nov 26 | Sale | 87.11 | 26,000 | 2,264,985 | 176,783 | Nov 26 08:45 PM | | SHARER KEVIN W | Director | Oct 24 | Option Exercise | 71.88 | 195,000 | 14,016,600 | 296,018 | Oct 25 06:32 PM | | SHARER KEVIN W | Director | Oct 24 | Sale | 88.13 | 263,000 | 23,178,598 | 5,494 | Oct 25 06:32 PM | | SHARER KEVIN W | Director | Sep 11 | Option Exercise | 61.36 | 274,625 | 16,849,739 | 375,643 | Sep 12 05:24 PM | | SHARER KEVIN W | Director | Sep 11 | Sale | 83.96 | 349,625 | 29,355,365 | 73,494 | Sep 12 05:24 PM | | SCHAEFFER LEONARD D | Director | Aug 30 | Option Exercise | 74.89 | 5,000 | 374,450 | 21,316 | Aug 31 06:00 PM | | SCHAEFFER LEONARD D | Director | Aug 30 | Sale | 83.25 | 5,000 | 416,254 | 16,316 | Aug 31 06:00 PM | | PELHAM JUDITH C | Director | Aug 24 | Option Exercise | 74.89 | 5,000 | 374,450 | 26,304 | Aug 27 06:53 PM | | PELHAM JUDITH C | Director | Aug 24 | Sale | 84.37 | 5,000 | 421,833 | 21,304 | Aug 27 06:53 PM | | REASON J PAUL | Director | Aug 09 | Sale | 81.93 | 4,500 | 368,692 | 23,591 | Aug 13 06:56 PM | | REASON J PAUL | Director | Aug 06 | Option Exercise | 53.65 | 25,000 | 1,341,200 | 44,408 | Aug 08 06:14 PM | | RICHO ANNA | SVP & CCO | Aug 01 | Option Exercise | 62.63 | 5,125 | 320,979 | 41,992 | Aug 01 07:50 PM | | RICHO ANNA | SVP & CCO | Aug 01 | Sale | 83.06 | 5,125 | 425,698 | 10,256 | Aug 01 07:50 PM | | Dittrich Thomas J.W. | VP, Finance & CAO | Jul 31 | Option Exercise | 65.28 | 32,150 | 2,098,645 | 45,871 | Aug 01 07:39 PM | | Dittrich Thomas J.W. | VP, Finance & CAO | Jul 31 | Sale | 82.69 | 32,150 | 2,658,387 | 13,721 | Aug 01 07:39 PM | | SCOTT DAVID J | SVP, Gen. Counsel & Secy. | Jul 30 | Option Exercise | 58.60 | 113,500 | 6,651,180 | 179,058 | Jul 31 08:00 PM | | REASON J PAUL | Director | Jul 30 | Option Exercise | 73.27 | 10,000 | 732,650 | 28,139 | Jul 31 07:21 PM | | BONANNI FABRIZIO | EVP, Operations | Jul 30 | Sale | 84.33 | 12,137 | 1,023,562 | 48,491 | Jul 31 07:31 PM | | SCOTT DAVID J | SVP, Gen. Counsel & Secy. | Jul 30 | Sale | 84.11 | 113,500 | 9,546,578 | 65,558 | Jul 31 08:00 PM | | BIONDI FRANK | Director | Jul 27 | Option Exercise | 48.72 | 21,000 | 1,023,130 | 48,785 | Jul 31 07:14 PM | | BONANNI FABRIZIO | EVP, Operations | Jul 27 | Option Exercise | 54.53 | 303,011 | 16,522,165 | 376,510 | Jul 31 07:31 PM | | Harper Sean E | EVP, Research & Development | Jul 27 | Option Exercise | 68.43 | 39,900 | 2,730,172 | 84,332 | Jul 31 07:35 PM | | SHARER KEVIN W | Director | Jul 27 | Option Exercise | 46.29 | 128,000 | 5,924,480 | 228,979 | Jul 31 07:26 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Jul 27 | Option Exercise | 62.53 | 85,098 | 5,321,035 | 138,387 | Jul 31 07:46 PM | | RICHO ANNA | SVP & CCO | Jul 27 | Option Exercise | 71.88 | 7,875 | 566,055 | 44,742 | Jul 31 07:52 PM | | RICHO ANNA | SVP & CCO | Jul 27 | Sale | 81.81 | 7,875 | 644,230 | 10,256 | Jul 31 07:52 PM | | MCNAMEE BRIAN M | SVP, Human Resources | Jul 27 | Sale | 82.73 | 85,598 | 7,081,859 | 52,789 | Jul 31 07:46 PM | | Harper Sean E | EVP, Research & Development | Jul 27 | Sale | 82.33 | 39,900 | 3,285,087 | 52,432 | Jul 31 07:35 PM | | BONANNI FABRIZIO | EVP, Operations | Jul 27 | Sale | 82.14 | 303,011 | 24,888,718 | 60,628 | Jul 31 07:31 PM | | SHARER KEVIN W | Director | Jul 27 | Sale | 82.68 | 128,000 | 10,583,347 | 148,494 | Jul 31 07:26 PM | | BIONDI FRANK | Director | Jul 27 | Sale | 82.30 | 21,000 | 1,728,300 | 27,785 | Jul 31 07:14 PM | | SCOTT DAVID J | SVP, Gen. Counsel & Secy. | Jul 27 | Sale | 82.00 | 30,000 | 2,460,000 | 65,558 | Jul 31 08:00 PM |
|
